New injection aims to ease bone cancer pain and prevent fractures
NCT ID NCT06380881
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested an investigational drug called SHR-2017 in 25 adults with solid tumors that spread to the bone. The goal was to see how the drug moves through the body, whether it reduces pain and bone complications, and how safe it is. Participants had at least one bone metastasis and moderate to severe pain despite stable pain medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China